Kick the Habit: How Nurse-Led Programs Can Help You Quit Smoking for Good
"Discover the power of nurse-led interventions and innovative strategies to boost your chances of successfully quitting smoking."
Smoking remains a significant public health challenge, with grave disparities in smoking prevalence existing between indigenous Māori, Pacific Island peoples, and other New Zealanders. While many smokers express a desire to quit, achieving lasting success can be difficult. Primary care nurses play a crucial role in delivering brief stop-smoking interventions, yet they often face constraints related to time and resources.
Innovative approaches that harness new technologies and creative engagement strategies offer promising avenues to enhance these brief interventions and improve both uptake and outcomes. These methods aim to make the process more accessible, motivating, and tailored to the unique needs of diverse populations.
One such innovation involves integrating a novel scratch card and internet-based "quit and win" contest, complemented by mobile phone support messages, into the standard practice of nurses' brief smoking cessation interventions. This approach aims to add an element of fun and competition to what can often be a daunting process, potentially boosting efficacy and engagement.
Widespread Desire to Quit
Most adults who smoke cigarettes want to quit, and about half report having tried to quit in the past year, according to CDC data. Cessation support is commonly offered over the telephone through quitlines—including the US toll-free number 1-800-QUIT-NOW—or in person. The frequency of smoking cessation among smokers varies across countries, reflecting differences in support systems and other factors. In research settings, successful quitting is typically measured as abstinence from smoking maintained for at least six months of follow-up.
Standard Methods and Their Limits
Standard cessation methods rest on a foundation of counseling and pharmacotherapy, with the Surgeon General's report on smoking cessation serving as a key reference for clinical practice. Smoking cessation is the most important treatment for smokers with chronic obstructive pulmonary disease, but little is known about the effectiveness of different interventions for this specific group of smokers. Programs also face the challenge of reaching diverse populations; one study tested a culturally adapted intervention delivered through eight weekly individualized counseling sessions against a standard cognitive behavioral therapy comparison arm. Despite these gaps, high rates of cessation observed in the population are neither accidental nor the result of aging or other demographic shifts, pointing to the real impact of organized cessation support.
From the 1800s to Today
The history of smoking cessation stretches back to the later 1800s, with exhibits tracing the evolution of cessation efforts up through the present day. Despite these decades of progress, cigarette smoking remains the second leading cause of preventable death worldwide. In Vietnam, for example, tobacco consumption remains high despite recent cessation efforts, particularly among males, illustrating how the challenge persists in some regions. Clinicians also rely on practical measures such as pack-year calculations—multiplying packs smoked per day by years of smoking—to gauge cumulative exposure and guide cessation support.
The "Cow Pat Quit and Win" Study: A Pilot Project
To explore the feasibility and potential impact of this innovative approach, researchers conducted a pragmatic exploratory mixed-methods pilot study. This study sought to determine if adding a "Cow Pat Quit and Win" (CPQ&W) contest to routine ABC (Ask, Brief Advice, Cessation support) interventions could improve patient engagement and quit rates.
- Assessing the feasibility of incorporating CPQ&W into routine ABC interventions.
- Evaluating the acceptability of the program to both nurses and patients.
- Gaining insights into the program's effect on quit attempts, particularly among Māori, Pacific Islanders, and young smokers.
A Living Field of Study
Recent research continues to reinforce the value of quitting at any point: one study confirms it is 'never too late' to see survival benefits from quitting smoking, even for patients with late-stage cancer. Investigators are also studying real-world prescribing patterns, including prescription smoking-cessation medication pharmacy claims after stroke and transient ischemic attack. Other research has examined whether a set of unique characteristics distinguishes adult smokers who successfully quit using e-cigarettes. Journals such as the Journal of Smoking Cessation and news aggregators track these developments as they emerge, reflecting an active and ongoing research agenda.
Honest Limits of Cessation
Quitting is not always straightforward, and the limits of treatments deserve honest attention. The ORCA-3 phase 3 trial of cytisinicline, for example, reported on quit rates and adverse effects while questioning how well an intensive trial protocol translates to everyday practice. Even so, the stakes remain high: tobacco use is the most common preventable cause of death, and former smokers retain only about a quarter of the excess risk of death that current smokers face. The difficulties and failures of specific treatments should not obscure the clear benefits of successful cessation.
Head-to-Head Treatment Comparisons
Head-to-head comparisons of cessation treatments offer a mixed but instructive picture. A Cochrane review established the effectiveness and safety of nicotine replacement therapy for achieving long-term cessation compared with placebo or no NRT. When NRT is compared with other options, the evidence is less clear: the certainty of evidence for nicotine-containing e-cigarettes versus NRT was deemed low, owing to imprecision and methodological issues in the included studies. Likewise, documentation was considered too insufficient to determine whether differences exist between bupropion and nicotine replacement therapies at 52 weeks.
The Path Forward: Implications and Future Research
While the CPQ&W pilot study showed promise in engaging specific populations and refreshing existing interventions, further research is needed to optimize its effectiveness and address limitations such as internet access disparities. Larger, properly powered studies are essential to test the efficacy of scratch card-based quit and win concepts, delivered by community nurses and other health professionals, and modified to accommodate low access to the internet. By refining these innovative approaches, we can move closer to achieving equitable reductions in smoking rates and supporting all individuals on their journey to a smoke-free life.
Expert Consensus and the Treatment Gap
Experts consistently stress that many smokers need more than willpower alone: an estimated 70% of patients want to quit, about 50% report a quit attempt in the past year, yet only 4-7% are successful. These low quit rates underscore the importance of treatment combining behavioral and pharmacotherapeutic means. On the delivery side, experts believe mHealth interventions can augment cessation support but should not replace human-driven care, with a blended approach integrating digital tools and traditional therapeutic relationships offering the most promise. Experts also note practical realities, including the view that some non-FDA-approved options are almost certainly safer than continuing to smoke for smokers unwilling or unable to quit.
The Road Ahead
Federal reports continue to map the past, present, and future of tobacco cessation in the United States, framing the direction of public health strategy. Emerging products are reshaping the landscape: the global e-cigarette market is forecast to expand from USD 26.0 billion in 2025 to USD 41.8 billion by 2034, a compound annual growth rate of 5.44%. Research is also identifying new behavioral signals, with studies suggesting that cigarette fading behaviors can predict future cessation; in one small study, 11% of smokers receiving cessation-contingent incentives reported quitting, compared with none in the control group.
Costs, Campaigns, and System Support
Smoking cessation operates within a broader public health and economic context. Cessation can save years of life at very low cost compared with alternative interventions, making it a highly cost-effective investment for health systems. Public education plays a supporting role: the CDC's Tips From Former Smokers campaign features real people who have suffered as a result of smoking and exposure to secondhand smoke, while materials such as 'FDA 101: Smoking Cessation Products' explain how FDA-approved medicines can help people quit. Together, these systemic supports address both the financial and social barriers that individual quitters face.
Meeting Smokers in the Moment
The human element of quitting is intensely personal, and researchers are now studying how to reach smokers at the moments that matter. Cessation treatments that are easily accessible and deliver intervention content at vulnerable moments—such as times of high negative affect—have great potential to improve tobacco abstinence. One study examined the feasibility and acceptability of a multi-component Just-In-Time intervention built around this principle. This real-time, real-world knowledge of the mechanisms behind relapse can ultimately be used to reduce the public health burden of tobacco use.